메뉴 건너뛰기
Journal of Neuro-Oncology
Volumn 73, Issue 2, 2005, Pages 185-
Maintenance of fertility following treatment with temozolomide for a high grade astrocytoma
Author keywords

[No Author keywords available]
Indexed keywords

TEMOZOLOMIDE;
EID: 22144477176     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11060-004-3577-y     Document Type: Letter
Times cited : (12)
References (5)
  • 1
    • 0025085679 scopus 로고
    • Long term fertility and Leydig cell function in patients treated for germ cell cancer with cisplatin, vinblastine, and bleomycin versus surveillance
    • 1698935
    • SW Hanson JG Berthelsen H. Maase von der 1990 Long term fertility and Leydig cell function in patients treated for germ cell cancer with cisplatin, vinblastine, and bleomycin versus surveillance J Clin Oncol 8 1695-1698 1698935
    • (1990) J. Clin. Oncol. , vol.8 , pp. 1695-1698
    • Hanson, S.W.1    Berthelsen, J.G.2    von der Maase, H.3
  • 2
    • 0346121847 scopus 로고    scopus 로고
    • Infertility rates following POMB/ACE chemotherapy for male and female germ cell tumours-a retrospective long-term follow-up study
    • 10.1038/sj.bjc.6601383 1:CAS:528:DC%2BD3sXovVersLs%3D 14612891
    • J Gaffan L Holden ES Newlands 2003 Infertility rates following POMB/ACE chemotherapy for male and female germ cell tumours-a retrospective long-term follow-up study Brit J Cancer 89 1849-1854 10.1038/ sj.bjc.6601383 1:CAS:528:DC%2BD3sXovVersLs%3D 14612891
    • (2003) Brit. J. Cancer , vol.89 , pp. 1849-1854
    • Gaffan, J.1    Holden, L.2    Newlands, E.S.3
  • 3
    • 0021368080 scopus 로고
    • DNA cross-linking and cytotoxicity in normal and transformed human cells treated in vitro with 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one
    • 1:STN:280:BiuC1c%2FjslA%3D 6713381
    • NW Gibson JA Hickman LC. Erickson 1984 DNA cross-linking and cytotoxicity in normal and transformed human cells treated in vitro with 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one Cancer Res 44 1772-1775 1:STN:280:BiuC1c%2FjslA%3D 6713381
    • (1984) Cancer Res. , vol.44 , pp. 1772-1775
    • Gibson, N.W.1    Hickman, J.A.2    Erickson, L.C.3
  • 4
    • 0035108398 scopus 로고    scopus 로고
    • Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse
    • 10.1023/A:1008382516636 1:STN:280:DC%2BD3M3gvFamtg%3D%3D 11300335
    • M Brada K Hoang-Xuan R Rampling 2001 Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse Ann Oncol 12 259-266 10.1023/A:1008382516636 1:STN:280:DC%2BD3M3gvFamtg%3D%3D 11300335
    • (2001) Ann. Oncol. , vol.12 , pp. 259-266
    • Brada, M.1    Hoang-Xuan, K.2    Rampling, R.3
  • 5
    • 10044277932 scopus 로고    scopus 로고
    • Concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) for newly diagnosed glioblastoma multiforme (GBM). Conclusive results of a randomised phase III trial by the EORTC brain and RT group and NCIC clinical trials group
    • Abs 2
    • Stupp R, Mason M, Van Den Bent M et al.: Concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) for newly diagnosed glioblastoma multiforme (GBM). Conclusive results of a randomised phase III trial by the EORTC brain and RT group and NCIC clinical trials group. Proc Am Soc Clin Oncol 2004, 1, Abs 2.
    • (2004) Proc. Am. Soc. Clin. Oncol. , pp. 1
    • Stupp, R.1    Mason, M.2    Van Den Bent, M.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.